VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$557.96
arrow_upward
+0.22%(+1.21) 1D
$559.00
arrow_upward
+0.19% (+1.04)bedtimeAfter hours
Closed: Sep 3, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$559.00
High
$560.25
Low
$551.61
Mkt. cap
141.42B
Avg. vol.
1.24M
Volume
800.81K
P/E ratio
32.46
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$559.00
High
$560.25
Low
$551.61
Mkt. cap
141.42B
Avg. vol.
1.24M
Volume
800.81K
P/E ratio
32.46
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Investing.com
·
6 hours ago
Vertex Tops Citi’s Biotech Picks After Crinetics Deal Completion
Yahoo Finance
·
1 day ago
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?
Zacks
·
1 day ago
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Yahoo Finance
·
1 day ago
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com